Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of R-ACVBP Regimen Supported by Pegfilgrastim in Previously Untreated Patients Aged From 18 to 60 Years With High-Risk Diffuse Large B-Cell Lymphoma (Age-adjusted Ipi >or= 2)

NCT00169143 is registered in ClinicalTrials.gov with Lymphoma Study Association as lead sponsor.

NCT NCT00169143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00169143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of R-ACVBP Regimen Supported by Pegfilgrastim in Previously Untreated Patients Aged From 18 to 60 Years With High-Risk Diffuse Large B-Cell Lymphoma (Age-adjusted Ipi >or= 2)
Lead sponsor
Lymphoma Study Association
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2004
Completion date
January 31, 2007
Enrollment
60
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

untreated cd20-positive large b-cell lymphoma